Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-23-010900
Filing Date
2023-02-14
Accepted
2023-02-13 17:48:34
Documents
1
Group Members
VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO SCHEDULE 13G ea173392-13ga4vivo9_mereo.htm SC 13G/A 82256
  Complete submission text file 0001213900-23-010900.txt   83766
Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo Biopharma Group plc (Subject) CIK: 0001719714 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91444 | Film No.: 23620441
SIC: 2834 Pharmaceutical Preparations

Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Filed by) CIK: 0001750698 (see all company filings)

EIN.: 824768569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A